RAMONADADURAMONA DADU9748DADU, RAMONAAssistant Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25353071Dadu R, Shah K, Busaidy NL, Waguespack SG, Habra MA, Ying AK, Hu MI, Bassett R, Jimenez C, Sherman SI, Cabanillas METhe Journal of clinical endocrinology and metabolismEfficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary thyroid cancer: M.D. Anderson Cancer Center off label experience. J Clin Endocrinol Metab. 2015 Jan; 100(1):E77-81.J Clin Endocrinol Metab2015-01-01T00:00:002015Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary thyroid cancer: M.D. Anderson Cancer Center off label experience.1515 Holcombe Blvd.Houston77030TXAuthorship 1837264Authorship 1847143Authorship 1857344Authorship 1872645Authorship 1885342Authorship 1900463Authorship 1943722Authorship 1944221Authorship 1948121Authorship 1952295Endocrine Neoplasia & HDInvestigational Cancer TherapeuticsLeukemiaSurgical OncologyMD AndersonSTEVEN ISHERMANSTEVEN I SHERMAN8436SHERMAN, STEVEN IProfessorVIVEKSUBBIAHVIVEK SUBBIAH9518SUBBIAH, VIVEKAssistant ProfessorHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorMIMI I-NANHUMIMI I-NAN HU8735HU, MIMI I-NANAssociate ProfessorMICHELLE DIANNEWILLIAMSMICHELLE DIANNE WILLIAMS9173WILLIAMS, MICHELLE DIANNEAssociate ProfessorNAIFA LBUSAIDYNAIFA L BUSAIDY9203BUSAIDY, NAIFA LAssociate Professor5.203480.00818204267research areas6.895860.0311819103coauthor of134.23615.219960similar to1175selected publicationsMARIA ECABANILLASMARIA E CABANILLAS8975CABANILLAS, MARIA EAssociate ProfessorSTEVEN GWAGUESPACKSTEVEN G WAGUESPACK9047WAGUESPACK, STEVEN GProfessorELIZABETH GARDNERGRUBBSELIZABETH GARDNER GRUBBS9340GRUBBS, ELIZABETH GARDNERAssociate ProfessorAuthorship 258890123235190Dadu R, Cabanillas MEMinerva endocrinologicaOptimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: current state of the art and future directions. Minerva Endocrinol. 2012 Dec; 37(4):335-56.Minerva Endocrinol2012-12-01T00:00:002012Optimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: current state of the art and future directions.25052450Cabanillas ME, Dadu R, Lai SYThe oncologistIn reply. Oncologist. 2014 Aug; 19(8):e4.Oncologist2014-07-22T00:00:002014In reply.26200040Dadu R, Hu MI, Cleeland C, Busaidy NL, Habra M, Waguespack SG, Sherman SI, Ying A, Fox P, Cabanillas METhyroid : official journal of the American Thyroid AssociationEfficacy of the Natural Clay, Calcium Aluminosilicate Anti-Diarrheal, in Reducing Medullary Thyroid Cancer-Related Diarrhea and Its Effects on Quality of Life: A Pilot Study. Thyroid. 2015 Oct; 25(10):1085-90.Thyroid2015-08-20T00:00:002015Efficacy of the Natural Clay, Calcium Aluminosilicate Anti-Diarrheal, in Reducing Medullary Thyroid Cancer-Related Diarrhea and Its Effects on Quality of Life: A Pilot Study.26494392Dadu R, Hu MN, Grubbs EG, Gagel RFRecent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancerUse of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma. Recent Results Cancer Res. 2015; 204:227-49.Recent Results Cancer Res2015-01-01T00:00:002015Use of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma.26527938Dadu RT, Dadu R, Zane SClujul medical (1957)Unusual presentation of endocarditis with nutritional variant Streptococci. Clujul Med. 2013; 86(2):153-5.Clujul Med2013-05-09T00:00:002013Unusual presentation of endocarditis with nutritional variant Streptococci.26568552Cabanillas ME, Dadu R, Hu MI, Lu C, Gunn GB, Grubbs EG, Lai SY, Williams MDHematology/oncology clinics of North AmericaThyroid Gland Malignancies. Hematol Oncol Clin North Am. 2015 Dec; 29(6):1123-43.Hematol Oncol Clin North Am2015-12-01T00:00:002015Thyroid Gland Malignancies.74Professor10Assistant Professor14Associate Professor26206754Ozsari L, Kutahyalioglu M, Elsayes KM, Vicens RA, Sircar K, Jazaerly T, Waguespack SG, Busaidy NL, Cabanillas ME, Dadu R, Hu MI, Vassilopoulou-Sellin R, Jimenez C, Lee JE, Habra MAEndocrinePreexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis. Endocrine. 2016 Feb; 51(2):351-9.Endocrine2015-07-25T00:00:002015Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis.Authorship 3737742Authorship 373784228068873Rao SN, Zafereo M, Dadu R, Busaidy NL, Hess K, Cote GJ, Williams MD, William WN, Sandulache V, Gross N, Gunn GB, Lu C, Ferrarotto R, Lai SY, Cabanillas METhyroid : official journal of the American Thyroid AssociationPatterns of Treatment Failure in Anaplastic Thyroid Carcinoma. Thyroid. 2017 05; 27(5):672-681.Thyroid2017-02-16T00:00:002017Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.Authorship 845412Authorship 846609Authorship 847009Authorship 850957Authorship 852850Authorship 864300Authorship 864405EndocrinePreexisting adrenal masses in patients with adrenocortical carcinoma. Endocrine. Preexisting adrenal masses in patients with adrenocortical carcinomaThyroidEfficacy of the natural clay, calcium aluminosilicate anti-diarrheal, in reducing medullary thyroid cancer-related diarrhea and its effects on quality of life. Thyroid. 25:1085-1090.Efficacy of the natural clay, calcium aluminosilicate anti-diarrheal, in reducing medullary thyroid cancer-related diarrhea and its effects on quality of lifeJournal of Clinical Endocrinology and MetabolismBone metastases and skeletal-related events in medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism. 101:4871-4877.Bone metastases and skeletal-related events in medullary thyroid carcinomaJournal of Clinical Endocrinology and MetabolismEfficacy and tolerability of vemurafenib in patients with BRAFV600E positive papillary thyroid cancer. Journal of Clinical Endocrinology and Metabolism. 100:E77-E81.Efficacy and tolerability of vemurafenib in patients with BRAFV600E positive papillary thyroid cancerCancer Journal (United States)Managing adverse events with immune checkpoint agents. Cancer Journal (United States). 22:121-129.Managing adverse events with immune checkpoint agentsThyroidMedullary Thyroid Carcinoma Associated with Germline RET<sup>K666N</sup> Mutation. Thyroid. 26:1744-1751.Medullary Thyroid Carcinoma Associated with Germline RET<sup>K666N</sup> MutationOncologistRe. Oncologist. 19.Re29161986Iyer PC, Dadu R, Ferrarotto R, Busaidy NL, Habra MA, Zafereo M, Gross N, Hess KR, Gule-Monroe M, Williams MD, Cabanillas METhyroid : official journal of the American Thyroid AssociationReal-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma. Thyroid. 2018 01; 28(1):79-87.Thyroid2017-12-21T00:00:002017Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma.Authorship 8865222Authorship 8872342Authorship 8873571Authorship 88738210Authorship 8875423Authorship 8876031Authorship 8881911Authorship 8887672D013964Disorders36218630.446935Thyroid NeoplasmsD010671Chemicals & Drugs2415780.752496Phenylurea CompoundsD051096Chemicals & Drugs943710.804305Proto-Oncogene Proteins c-retD018278Disorders2517140.620327Carcinoma, NeuroendocrineAuthorship 9051627Authorship 9069633Authorship 9115818Authorship 9162518Authorship 9229677Authorship 9290138Authorship 9303287Authorship 93072710Authorship 9350732Authorship 9353967Authorship 935571627111908Dadu R, Zobniw C, Diab ACancer journal (Sudbury, Mass.)Managing Adverse Events With Immune Checkpoint Agents. Cancer J. 2016 Mar-Apr; 22(2):121-9.Cancer J2016-03-01T00:00:002016Managing Adverse Events With Immune Checkpoint Agents.27662441Xu JY, Murphy WA, Milton DR, Jimenez C, Rao SN, Habra MA, Waguespack SG, Dadu R, Gagel RF, Ying AK, Cabanillas ME, Weitzman SP, Busaidy NL, Sellin RV, Grubbs E, Sherman SI, Hu MIThe Journal of clinical endocrinology and metabolismBone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma. J Clin Endocrinol Metab. 2016 12; 101(12):4871-4877.J Clin Endocrinol Metab2016-09-23T00:00:002016Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma.27673361Xu JY, Grubbs EG, Waguespack SG, Jimenez C, Gagel RF, Sosa JA, Sellin RV, Dadu R, Hu MI, Trotter CS, Jackson M, Rich TA, Hyde SM, Sherman SI, Cote GJThyroid : official journal of the American Thyroid AssociationMedullary Thyroid Carcinoma Associated with Germline RETK666N Mutation. Thyroid. 2016 12; 26(12):1744-1751.Thyroid2016-10-18T00:00:002016Medullary Thyroid Carcinoma Associated with Germline RETK666N Mutation.29044788Pena I, Clayman GL, Grubbs EG, Bergeron JM, Waguespack SG, Cabanillas ME, Dadu R, Hu MI, Fellman BM, Li Y, Gross ND, Lai SY, Sturgis EM, Zafereo MEHead & neckManagement of the lateral neck compartment in patients with sporadic medullary thyroid cancer. Head Neck. 2018 Jan; 40(1):79-85.Head Neck2017-10-16T00:00:002017Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer.29408964Jaber T, Hyde SM, Cote GJ, Grubbs EG, Giles WH, Stevens CA, Dadu RThe Journal of clinical endocrinology and metabolismA Homozygous RET K666N Genotype With an MEN2A Phenotype. J Clin Endocrinol Metab. 2018 04 01; 103(4):1269-1272.J Clin Endocrinol Metab2018-04-01T00:00:002018A Homozygous RET K666N Genotype With an MEN2A Phenotype.29927883Sagiv O, Kandl TJ, Thakar SD, Thuro BA, Busaidy NL, Cabanillas M, Jimenez C, Dadu R, Graham PH, Debnam JM, Esmaeli BOphthalmic plastic and reconstructive surgeryExtraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients. Ophthalmic Plast Reconstr Surg. 2019 Jan/Feb; 35(1):50-52.Ophthalmic Plast Reconstr Surg2019-01-01T00:00:002019Extraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients.30141373Tam S, Boonsripitayanon M, Amit M, Fellman BM, Li Y, Busaidy NL, Cabanillas ME, Dadu R, Sherman S, Waguespack SG, Williams MD, Goepfert RP, Gross ND, Perrier ND, Sturgis EM, Zafereo METhyroid : official journal of the American Thyroid AssociationSurvival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions. Thyroid. 2018 10; 28(10):1301-1310.Thyroid2018-10-01T00:00:002018Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.29996921Iyer PC, Dadu R, Gule-Monroe M, Busaidy NL, Ferrarotto R, Habra MA, Zafereo M, Williams MD, Gunn GB, Grosu H, Skinner HD, Sturgis EM, Gross N, Cabanillas MEJournal for immunotherapy of cancerSalvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma. J Immunother Cancer. 2018 07 11; 6(1):68.J Immunother Cancer2018-07-11T00:00:002018Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma.30132401Iyer PC, Cabanillas ME, Waguespack SG, Hu MI, Thosani S, Lavis VR, Busaidy NL, Subudhi SK, Diab A, Dadu RThyroid : official journal of the American Thyroid AssociationImmune-Related Thyroiditis with Immune Checkpoint Inhibitors. Thyroid. 2018 10; 28(10):1243-1251.Thyroid2018-10-01T00:00:002018Immune-Related Thyroiditis with Immune Checkpoint Inhibitors.30022274Amit M, Boonsripitayanon M, Goepfert RP, Tam S, Busaidy NL, Cabanillas ME, Dadu R, Varghese J, Waguespack SG, Gross ND, Graham P, Williams MD, Sturgis EM, Zafereo MEAnnals of surgical oncologyExtrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer? Ann Surg Oncol. 2018 Oct; 25(11):3380-3388.Ann Surg Oncol2018-07-18T00:00:002018Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?30032208Jaber T, Waguespack SG, Cabanillas ME, Elbanan M, Vu T, Dadu R, Sherman SI, Amit M, Santos EB, Zafereo M, Busaidy NLThe Journal of clinical endocrinology and metabolismTargeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine. J Clin Endocrinol Metab. 2018 10 01; 103(10):3698-3705.J Clin Endocrinol Metab2018-10-01T00:00:002018Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine.PathologyAuthorship 941962730728076Abu-Sbeih H, Tang T, Lu Y, Thirumurthi S, Altan M, Jazaeri AA, Dadu R, Coronel E, Wang YJournal for immunotherapy of cancerClinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury. J Immunother Cancer. 2019 02 06; 7(1):31.J Immunother Cancer2019-02-06T00:00:002019Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury.Authorship 942868629742974Cabanillas ME, Ferrarotto R, Garden AS, Ahmed S, Busaidy NL, Dadu R, Williams MD, Skinner H, Gunn GB, Grosu H, Iyer P, Hofmann MC, Zafereo MThyroid : official journal of the American Thyroid AssociationNeoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma. Thyroid. 2018 07; 28(7):945-951.Thyroid2018-06-29T00:00:002018Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma.Authorship 944589930940209Abu-Sbeih H, Ali FS, Wang X, Mallepally N, Chen E, Altan M, Bresalier RS, Charabaty A, Dadu R, Jazaeri A, Lashner B, Wang YJournal for immunotherapy of cancerEarly introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis. J Immunother Cancer. 2019 04 02; 7(1):93.J Immunother Cancer2019-04-02T00:00:002019Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis.D065646Disorders742570.793756Thyroid Carcinoma, AnaplasticAuthorship 952194331309300Kutahyalioglu M, Nguyen HT, Kwatampora L, Clarke C, Silva A, Ibrahim E, Waguespack SG, Cabanillas ME, Jimenez C, Hu MI, Sherman SI, Kopetz S, Broaddus R, Dadu R, Wanland K, Williams M, Zafereo M, Perrier N, Busaidy NLJournal of cancer research and clinical oncologyGenetic profiling as a clinical tool in advanced parathyroid carcinoma. J Cancer Res Clin Oncol. 2019 Aug; 145(8):1977-1986.J Cancer Res Clin Oncol2019-07-15T00:00:002019Genetic profiling as a clinical tool in advanced parathyroid carcinoma.31319771Wang JR, Zafereo ME, Dadu R, Ferrarotto R, Busaidy NL, Lu C, Ahmed S, Gule-Monroe MK, Williams MD, Sturgis EM, Goepfert RP, Gross ND, Lai SY, Gunn GB, Phan J, Rosenthal DI, Fuller CD, Morrison WH, Iyer P, Cabanillas METhyroid : official journal of the American Thyroid AssociationComplete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma. Thyroid. 2019 08; 29(8):1036-1043.Thyroid2019-08-01T00:00:002019Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma.Authorship 95324114Authorship 956406531583077Cabanillas ME, Zafereo M, Williams MD, Ferrarotto R, Dadu R, Gross N, Gunn GB, Skinner H, Cote G, Grosu HB, Iyer P, Busaidy NLF1000ResearchRecent advances and emerging therapies in anaplastic thyroid carcinoma. F1000Res. 2018; 7.F1000Res2018-01-18T00:00:002018Recent advances and emerging therapies in anaplastic thyroid carcinoma.Authorship 9580262431658994Welsh JW, Tang C, de Groot P, Naing A, Hess KR, Heymach JV, Papadimitrakopoulou VA, Cushman TR, Subbiah V, Chang JY, Simon GR, Ramapriyan R, Barsoumian HB, Menon H, Cortez MA, Massarelli E, Nguyen Q, Sharma P, Allison JP, Diab A, Verma V, Raju U, Shaaban SG, Dadu R, Cabanillas ME, Wang K, Anderson C, Gomez DR, Hahn S, Komaki R, Hong DSCancer immunology researchPhase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses. Cancer Immunol Res. 2019 12; 7(12):1903-1909.Cancer Immunol Res2019-10-28T00:00:002019Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses.Authorship 980121232216548Cabanillas ME, Dadu R, Iyer P, Wanland KB, Busaidy NL, Ying A, Gule-Monroe M, Wang JR, Zafereo M, Hofmann MCThyroid : official journal of the American Thyroid AssociationAcquired Secondary RAS Mutation in BRAFV600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors. Thyroid. 2020 09; 30(9):1288-1296.Thyroid2020-05-07T00:00:002020Acquired Secondary RAS Mutation in BRAFV600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors.Authorship 9899151432437031Jozaghi Y, Zafereo ME, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PHHead & neckEndocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head Neck. 2020 06; 42(6):1325-1328.Head Neck2020-04-30T00:00:002020Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines.Authorship 9926131Authorship 992624132580150Dadu R, Bagheri-Yarmand R, Ringel MD, Grubbs EG, Zafereo M, Cote G, Gagel RF, Robinson BG, Shaw KR, Hu MIEndocrine-related cancerHEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The state of science in medullary thyroid carcinoma: current challenges and unmet needs. Endocr Relat Cancer. 2020 08; 27(8):T27-T39.Endocr Relat Cancer2020-08-01T00:00:002020HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The state of science in medullary thyroid carcinoma: current challenges and unmet needs.32581059Dadu R, Rodgers TE, Trinh VA, Kemp EH, Cubb TD, Patel S, Simon JM, Burton EM, Tawbi HJournal for immunotherapy of cancerCalcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy: diagnosis and long-term follow-up. J Immunother Cancer. 2020 06; 8(1).J Immunother Cancer2020-06-01T00:00:002020Calcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy: diagnosis and long-term follow-up.Authorship 996219232761153Maniakas A, Dadu R, Busaidy NL, Wang JR, Ferrarotto R, Lu C, Williams MD, Gunn GB, Hofmann MC, Cote G, Sperling J, Gross ND, Sturgis EM, Goepfert RP, Lai SY, Cabanillas ME, Zafereo MJAMA oncologyEvaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019. JAMA Oncol. 2020 09 01; 6(9):1397-1404.JAMA Oncol2020-09-01T00:00:002020Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019.Authorship 10034721133097651Hegde A, Andreev-Drakhlin AY, Roszik J, Huang L, Liu S, Hess K, Cabanillas M, Hu MI, Busaidy NL, Sherman SI, Dadu R, Grubbs EG, Ali SM, Lee J, Elamin YY, Simon GR, Blumenschein GR, Papadimitrakopoulou VA, Hong D, Meric-Bernstam F, Heymach J, Subbiah VESMO openResponsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies. ESMO Open. 2020 10; 5(5):e000799.ESMO Open2020-10-01T00:00:002020Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies.Authorship 10047731033169506Jozaghi Y, Zafereo M, Williams MD, Gule-Monroe MK, Wang J, Grubbs EG, Vaporciyan A, Hu MI, Busaidy N, Dadu R, Waguespack SG, Subbiah V, Cabanillas MHead & neckNeoadjuvant selpercatinib for advanced medullary thyroid cancer. Head Neck. 2021 01; 43(1):E7-E12.Head Neck2020-11-09T00:00:002020Neoadjuvant selpercatinib for advanced medullary thyroid cancer.Authorship 1006246333267782Datar S, Cabanillas M, Dadu R, Ost D, Grosu HBBMC cancerPulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents. BMC Cancer. 2020 Dec 02; 20(1):1181.BMC Cancer2020-12-02T00:00:002020Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents.Authorship 1008360733409738Abdel-Wahab N, Diab A, Yu RK, Futreal A, Criswell LA, Tayar JH, Dadu R, Shannon V, Shete SS, Suarez-Almazor MECancer immunology, immunotherapy : CIIGenetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors. Cancer Immunol Immunother. 2021 Jul; 70(7):1939-1949.Cancer Immunol Immunother2021-01-07T00:00:002021Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors.Authorship 1010557233536187Bagheri-Yarmand R, Dadu R, Ye L, Shiny Jebaraj Y, Martinez JA, Ma J, Tarapore RS, Allen JE, Sherman SI, Williams MD, Gagel RFMolecular cancer therapeuticsONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of RET, VEGFR2, and IGFBP2. Mol Cancer Ther. 2021 04; 20(4):665-675.Mol Cancer Ther2021-02-03T00:00:002021ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of RET, VEGFR2, and IGFBP2.Authorship 10117527Authorship 10124903Authorship 1012520833599171Qin Y, Wang JR, Wang Y, Iyer P, Cote GJ, Busaidy NL, Dadu R, Zafereo M, Williams MD, Ferrarotto R, Gunn GB, Wei P, Patel K, Hofmann MC, Cabanillas METhyroid : official journal of the American Thyroid AssociationClinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma. Thyroid. 2021 08; 31(8):1235-1243.Thyroid2021-04-19T00:00:002021Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma.33641345Kim ST, Pundole X, Dadu R, Lambotte O, Ramos-Casals M, Suarez-Almazor MEImmunotherapyUse of immune checkpoint inhibitors in cancer patients with pre-existing sarcoidosis. Immunotherapy. 2021 04; 13(6):465-475.Immunotherapy2021-03-01T00:00:002021Use of immune checkpoint inhibitors in cancer patients with pre-existing sarcoidosis.33643693Lin JS, Mamlouk O, Selamet U, Tchakarov A, Glass WF, Sheth RA, Layman RM, Dadu R, Abdelwahab N, Abdelrahim M, Diab A, Yee C, Abudayyeh AOncoimmunologyInfliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis. Oncoimmunology. 2021 02 02; 10(1):1877415.Oncoimmunology2021-02-02T00:00:002021Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis.Authorship 10168761633890870Nguyen H, Shah K, Waguespack SG, Hu MI, Habra MA, Cabanillas ME, Busaidy NL, Bassett R, Zhou S, Iyer PC, Simmons G, Kaya D, Pitteloud M, Subudhi SK, Diab A, Dadu REndocrine-related cancerImmune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns. Endocr Relat Cancer. 2021 06 02; 28(7):419-431.Endocr Relat Cancer2021-06-02T00:00:002021Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns.Authorship 10246741634147031Maniakas A, Henderson YC, Hei H, Peng S, Chen Y, Jiang Y, Ji S, Cardenas M, Chiu Y, Bell D, Williams MD, Hofmann MC, Scherer SE, Wheeler DA, Busaidy NL, Dadu R, Wang JR, Cabanillas ME, Zafereo M, Johnson FM, Lai SYThe Journal of clinical endocrinology and metabolismNovel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity. J Clin Endocrinol Metab. 2021 10 21; 106(11):e4652-e4665.J Clin Endocrinol Metab2021-10-21T00:00:002021Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity.Authorship 1025858234292174Jaber T, Dadu R, Hu MICurrent opinion in endocrinology, diabetes, and obesityMedullary thyroid carcinoma. Curr Opin Endocrinol Diabetes Obes. 2021 10 01; 28(5):540-546.Curr Opin Endocrinol Diabetes Obes2021-10-01T00:00:002021Medullary thyroid carcinoma.Authorship 1039619935135166Iyer PC, Cote GJ, Hai T, Gule-Monroe M, Bui-Griffith J, Williams MD, Hess K, Hofmann MC, Dadu R, Zafereo M, Busaidy NL, Ferrarotto R, Subbiah V, Gross N, Gunn BG, Skinner HD, Garden AS, Cabanillas MEJCO precision oncologyCirculating BRAF V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid Carcinoma. JCO Precis Oncol. 2018 Nov; 2:1-11.JCO Precis Oncol2018-11-01T00:00:002018Circulating BRAF V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid Carcinoma.21138891Gheorghe C, Dadu R, Blot C, Barrantes F, Vazquez R, Berianu F, Feng Y, Feintzig I, Amoateng-Adjepong Y, Manthous CAChestHyperchloremic metabolic acidosis following resuscitation of shock. Chest. 2010 Dec; 138(6):1521-2.Chest2010-12-01T00:00:002010Hyperchloremic metabolic acidosis following resuscitation of shock.21194655Gheorghe C, Vazquez R, Casanegra AI, Argento V, Dadu R, Feng Y, Amoateng-Adjepong Y, Manthous CAJournal of the American Medical Directors AssociationElders' environs and their end-of-life preferences. J Am Med Dir Assoc. 2011 Jan; 12(1):22-8.J Am Med Dir Assoc2010-08-09T00:00:002010Elders' environs and their end-of-life preferences.22162892Kaufman DA, Ravi S, Dadu R, Horowitz D, Logue MAAmerican journal of respiratory and critical care medicineSevere hypoxemia and orthodeoxia following right pneumonectomy. Am J Respir Crit Care Med. 2011 Dec 01; 184(11):e1-2.Am J Respir Crit Care Med2011-12-01T00:00:002011Severe hypoxemia and orthodeoxia following right pneumonectomy.20209770Pop M, Ghigolea I, Muresan A, R?jnoveanu R, Dadu R, Pui ARevista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi[Tuberculosis or sarcoidosis]. Rev Med Chir Soc Med Nat Iasi. 2008 Oct-Dec; 112(4):959-64.Rev Med Chir Soc Med Nat Iasi2008-10-01T00:00:002008[Tuberculosis or sarcoidosis].20348197Vazquez R, Gheorghe C, Ramos F, Dadu R, Amoateng-Adjepong Y, Manthous CAChestGurgling breath sounds may predict hospital-acquired pneumonia. Chest. 2010 Aug; 138(2):284-8.Chest2010-03-26T00:00:002010Gurgling breath sounds may predict hospital-acquired pneumonia.21317989Parperis K, Dadu R, Hoq S, Argento VCase reports in medicineThyrotoxic Dysphagia in an 82-year-old male. Case Rep Med. 2011; 2011:929523.Case Rep Med2011-01-16T00:00:002011Thyrotoxic Dysphagia in an 82-year-old male.20578050Casanegra AI, Brannan S, Dadu R, Ong P, Berner M, Spinning K, Hughes T, Marrinan G, Zinn K, Manthous CJournal of hospital medicineShort-term femoral vein catheterization rarely causes thrombosis or bacteremia. J Hosp Med. 2011 Jan; 6(1):33-6.J Hosp Med2010-06-23T00:00:002010Short-term femoral vein catheterization rarely causes thrombosis or bacteremia.Authorship 106169912Authorship 105446621Authorship 10602199Authorship 1060794636524701Shenson JA, Zafereo ME, Lee M, Contrera KJ, Feng L, Boonsripitayanon M, Gross N, Goepfert R, Maniakas A, Wang JR, Grubbs L, Vaporciyan A, Hofstetter W, Swisher S, Mehran R, Rice D, Sepesi B, Antonoff M, Cabanillas M, Busaidy N, Dadu R, Silver NLHead & neckClinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancer. Head Neck. 2023 03; 45(3):547-554.Head Neck2022-12-16T00:00:002022Clinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancer.36503246Contrera KJ, Gule-Monroe MK, Hu MI, Cabanillas ME, Busaidy NL, Dadu R, Waguespack SG, Wang JR, Maniakas A, Lai SY, Diersing J, Kwon M, Grubbs EG, Subbiah V, Williams MD, Zafereo METhyroid : official journal of the American Thyroid AssociationNeoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. Thyroid. 2023 01; 33(1):129-132.Thyroid2023-01-01T00:00:002023Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series.35977347Wang JR, Montierth M, Xu L, Goswami M, Zhao X, Cote G, Wang W, Iyer P, Dadu R, Busaidy NL, Lai SY, Gross ND, Ferrarotto R, Lu C, Gunn GB, Williams MD, Routbort M, Zafereo ME, Cabanillas MEJCO precision oncologyImpact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma. JCO Precis Oncol. 2022 08; 6:e2100504.JCO Precis Oncol2022-08-01T00:00:002022Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma.36511380Chen YH, Cabanillas M, Sperling J, Xu L, Goswami M, Maniakas A, Williams MD, Lai SY, Busaidy N, Dadu R, Zafereo ME, Wang JRThyroid : official journal of the American Thyroid AssociationPrior Thyroid and Nonthyroid Cancer History Do Not Significantly Alter Overall Survival in Patients Diagnosed with Anaplastic Thyroid Cancer. Thyroid. 2023 03; 33(3):321-329.Thyroid2023-02-20T00:00:002023Prior Thyroid and Nonthyroid Cancer History Do Not Significantly Alter Overall Survival in Patients Diagnosed with Anaplastic Thyroid Cancer.Authorship 1063491336762947Zhao X, Wang JR, Dadu R, Busaidy NL, Xu L, Learned KO, Chasen NN, Vu T, Maniakas A, Eguia AA, Diersing J, Gross ND, Goepfert R, Lai SY, Hofmann MC, Ferrarotto R, Lu C, Gunn GB, Spiotto MT, Subbiah V, Williams MD, Cabanillas ME, Zafereo METhyroid : official journal of the American Thyroid AssociationSurgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAFV600E Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study. Thyroid. 2023 04; 33(4):484-491.Thyroid2023-03-20T00:00:002023Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAFV600E Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study.Authorship 106883418Authorship 1068526937013834Jeun R, Iyer PC, Best C, Lavis V, Varghese JM, Yedururi S, Brady V, Glitza Oliva IC, Dadu R, Milton DR, Brock K, Thosani SImmunotherapyClinical outcomes of immune checkpoint inhibitor diabetes mellitus at a comprehensive cancer center. Immunotherapy. 2023 04; 15(6):417-428.Immunotherapy2023-04-04T00:00:002023Clinical outcomes of immune checkpoint inhibitor diabetes mellitus at a comprehensive cancer center.37053016Lu L, Wang JR, Henderson YC, Bai S, Yang J, Hu M, Shiau CK, Pan T, Yan Y, Tran TM, Li J, Kieser R, Zhao X, Wang J, Nurieva R, Williams MD, Cabanillas ME, Dadu R, Busaidy NL, Zafereo M, Navin N, Lai SY, Gao RThe Journal of clinical investigationAnaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. J Clin Invest. 2023 06 01; 133(11).J Clin Invest2023-06-01T00:00:002023Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics.Authorship 1074209737435488Hamidi S, Hofmann MC, Iyer PC, Cabanillas ME, Hu MI, Busaidy NL, Dadu RFrontiers in endocrinologyReview article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance. Front Endocrinol (Lausanne). 2023; 14:1176731.Front Endocrinol (Lausanne)2023-06-26T00:00:002023Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance.Authorship 1083836638009416Maniakas A, Sullivan A, Hu MI, Busaidy NL, Cabanillas ME, Dadu R, Waguespack SG, Fisher SB, Graham PH, Gross ND, Grubbs EG, Perrier ND, Wang JR, Gunn B, Garden AS, Megahed R, Navuluri S, Li X, Williams MD, Zafereo MHead & neckDecreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer. Head Neck. 2024 Feb; 46(2):328-335.Head Neck2023-11-27T00:00:002023Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer.Authorship 1087283338226606Hamidi S, Iyer PC, Dadu R, Gule-Monroe MK, Maniakas A, Zafereo ME, Wang JR, Busaidy NL, Cabanillas METhyroid : official journal of the American Thyroid AssociationCheckpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAFV600E-Mutated Anaplastic Thyroid Carcinoma. Thyroid. 2024 Mar; 34(3):336-346.Thyroid2024-02-13T00:00:002024Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAFV600E-Mutated Anaplastic Thyroid Carcinoma.Authorship 10900242Authorship 1090227438441247Iyer PC, Dadu R, Barque A, Zanelli C, Zheng X, Jiang H, Walsh PS, Hao Y, Huang J, Klopper J, Kloos RT, Cabanillas MThe Journal of clinical endocrinology and metabolismAnalytical Validation of a Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay. J Clin Endocrinol Metab. 2024 Mar 05.J Clin Endocrinol Metab2024-03-05T00:00:002024Analytical Validation of a Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay.38438731Subbiah V, Gouda MA, Iorgulescu JB, Dadu R, Patel K, Sherman S, Cabanillas M, Hu M, Castellanos LE, Amini B, Meric-Bernstam F, Shen T, Wu JNPJ precision oncologyAdaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer. NPJ Precis Oncol. 2024 Mar 04; 8(1):62.NPJ Precis Oncol2024-03-04T00:00:002024Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer.true1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1Assistant ProfessorAssistant Professor24563075Thomas L, Lai SY, Dong W, Feng L, Dadu R, Regone RM, Cabanillas METhe oncologistSorafenib in metastatic thyroid cancer: a systematic review. Oncologist. 2014 Mar; 19(3):251-8.Oncologist2014-02-21T00:00:002014Sorafenib in metastatic thyroid cancer: a systematic review.24628550Dadu R, Devine C, Hernandez M, Waguespack SG, Busaidy NL, Hu MI, Jimenez C, Habra MA, Sellin RV, Ying AK, Cote GJ, Sherman SI, Cabanillas METhe Journal of clinical endocrinology and metabolismRole of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib. J Clin Endocrinol Metab. 2014 Jun; 99(6):2086-94.J Clin Endocrinol Metab2014-03-14T00:00:002014Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib.24635127Blevins DP, Dadu R, Hu M, Baik C, Balachandran D, Ross W, Gunn B, Cabanillas METhyroid : official journal of the American Thyroid AssociationAerodigestive fistula formation as a rare side effect of antiangiogenic tyrosine kinase inhibitor therapy for thyroid cancer. Thyroid. 2014 May; 24(5):918-22.Thyroid2014-03-17T00:00:002014Aerodigestive fistula formation as a rare side effect of antiangiogenic tyrosine kinase inhibitor therapy for thyroid cancer.24733667Dadu R, Waguespack SG, Sherman SI, Hu MI, Busaidy NL, Jimenez C, Habra MA, Ying AK, Bassett RL, Cabanillas METhe oncologistEfficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer. Oncologist. 2014 May; 19(5):477-82.Oncologist2014-04-14T00:00:002014Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer.